Pradeep Prakash

Behavioural Scientist. Pioneered Good Behavioural Practices (GBP) concept for GMP in Pharma.Culture Change consultant. Investment psychologist.

[Pradeep Prakash @mindaware]

@hvgoenka Only genius persons can live simple life; it is not for ordinary people.

[Pradeep Prakash @mindaware]

@BalakrishnanR @nsinghal211 Maruti

[Pradeep Prakash @mindaware]

@sandipsabharwal There was exceptionally high oi of more than 6.2 crore contracts at 24000 Will not be broken

[Pradeep Prakash @mindaware]

@Geetu_Moza What's the status now? Market has already discounted the mou on Friday what more rally now?

[Pradeep Prakash @mindaware]

@cadalukaanubhav There is no surprise, crude oil price drop will determine it

[Pradeep Prakash @mindaware]

@ankit_investing Itc hotel nahi hai isme ab

[TheLiverDoc™ @theliverdoc]

Dear friends, as promised, the citizens funded generics vs. branded drugs project is now published after 4 months in peer review. It was hardwork, but worth the effort because all of you helped us realize this important work.

You can read the full detaild paper here: https://t.co/jZhm8ZcPCq

Here is a simplified summary:
Do cheaper generic medicines work as well as expensive branded ones? It's a question that worries patients and even many doctors, who often quietly assume that a low price must mean lower quality. This doubt has real consequences in India, where medicines make up nearly two-thirds of what families spend out of their own pockets on healthcare — a burden that pushes millions into poverty and forces people to split doses or stop treatment altogether.

To put the question to a fair, independent test, our team at the Mission for Ethics and Science in Healthcare (MESH) carried out a fully citizen-funded study, paid for entirely by donations from ordinary members of the public, with no money or influence from any drug company.

We bought 131 samples of 22 commonly used medicines — covering heart disease, diabetes, infections, pain, acidity, and more — from seven different kinds of outlets across Kerala, including government stores like Jan Aushadhi, private generic chains, and premium branded pharmacies. Every sample was then coded, blinded, and sent to a top accredited laboratory for rigorous testing against the Indian Pharmacopoeia 2022 standards. What makes this study unusual is that very few before it have tested branded and generic versions from the same market side by side, included government-supplied medicines, and combined strict quality testing with a hard look at price — all at the same time.

The result was striking in its simplicity: every single one of the 131 medicines passed every quality test. 100%. It made no difference whether a pill was generic or branded, cheap or expensive — they were all equally good in their active ingredient content, their purity, and how they dissolve in the body.

Yet the prices told a completely different story. Generic medicines were, on average, 48.6% cheaper than their branded twins, and the most expensive brand cost up to 13.9 times more than the cheapest generic of the very same drug. Government Jan Aushadhi stores were the cheapest source for 18 of the 22 medicines tested, with potential savings running into thousands of rupees a year per medicine — for instance, over ₹16,000 a year on a single liver drug.

For doctors, this is reassuring, hard evidence that prescribing a quality-assured generic is not a compromise on care; it is the same medicine at a fraction of the cost. For patients, it means you can stay on your treatment without it draining your savings, which is exactly what keeps people healthier over the long run.

And this is precisely why independent, publicly funded projects like this matter so much for the future of healthcare in India: they answer the questions ordinary people actually have, free from commercial pressure, and they build the trust that programmes like Jan Aushadhi need to truly succeed. Affordable and high-quality are not opposites — in a well-regulated market, they go hand in hand.
More here: https://t.co/jZhm8ZcPCq

[Pradeep Prakash @mindaware]

@iamrakeshbansal Then buy PE options of Gold on MCX, without skin in the game this prediction is meaningless.

[Pradeep Prakash @mindaware]

@ETNOWlive Likely to be fake news on sensex expiry today

[Pradeep Prakash @mindaware]

@CNBCTV18Live @sunchartist @Sapna_CNBC My impression about you guys is that you are fake news implanters especially on sensex/ nifty expiry days. This seems to be in the same category. @NSEIndia @SEBI_India @BSEIndia

[Pradeep Prakash @mindaware]

@MashraniVivek High valuation of these companies seem to have priced in these growth catalysts?

[Pradeep Prakash @mindaware]

@REDBOXINDIA @NSEIndia @SEBI_India @BSEIndia

[Pradeep Prakash @mindaware]

@REDBOXINDIA I suspect some traders pay you to create fake news and you play in their hands in consort with cnbc

[Pradeep Prakash @mindaware]

On 29th May, 26 was MSCI balancing day and after 3.30 there was a drop of more than 150 points in 15 minutes as shown below:

Now this information was known that at 3 pm there will be massive outflow of more than 20000 cr of stocks. It could be used by anybody to buy puts at 2.55 pm or so or sell futures or CEs etc to hugely benefit from the same, right so easy. But market players are very intelligent, they kept the future unmoved or slightly moved and so were options . They behaved as if no fall of 150 points happened. Their value remained fixed or little bit of change from the nifty future of 25716 whereas spot closed at 23557(VVAP) etc. And today the market is opening as per future and not as per spot close of Friday which makes the option and future values having no impact of 150 points fall due to MSCI balancing. Amazing intelligence of market makers or lets say stock market?
Lot of persons on X were confused by the discount on PEs and premium on CEs. See below the option prices at close on Friday and you will see discount on PE prices and Premium on CE options based on spot

[Harsh Mariwala @hcmariwala]

Some leaders have mentors. Some have advisors. This one has 2 risk managers with paws.

#smalljoys #leadership #riskmanagement

[Pradeep Prakash @mindaware]

@Prakashplutus It is not discount future synthetic is at 23710 or so

[Pradeep Prakash @mindaware]

@kirubaakaran They are doing the similar games in us markets and crypto and gold and silver with boldness never seen in the history

[Pradeep Prakash @mindaware]

@NeelChhabra The ROE AND ROCE in the range of9.5% only. What does that mean?